Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.
Effective, pangenotypic treatments for hepatitis C virus (HCV) infection are needed. ⋯ Gilead Sciences.
-
Randomized Controlled Trial Multicenter Study
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.
Effective treatment options are needed for patients with genotype 1 or 3 hepatitis C virus (HCV) infection in whom previous therapy has failed. ⋯ Gilead Sciences.